DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets
Open Access
- 21 October 2004
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 5 (8), 597-608
- https://doi.org/10.1038/sj.gene.6364132
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT‐1 pathway between rheumatoid tissuesArthritis & Rheumatism, 2003
- Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repairGenes & Immunity, 2003
- Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferationArthritis Research & Therapy, 2002
- Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reactionArthritis & Rheumatism, 2002
- Molecular portraits of human breast tumoursNature, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Discovery and analysis of inflammatory disease-related genes using cDNA microarraysProceedings of the National Academy of Sciences, 1997
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990